Chunlei Zhou

1.7k total citations
74 papers, 1.1k citations indexed

About

Chunlei Zhou is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Chunlei Zhou has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Neurology. Recurrent topics in Chunlei Zhou's work include Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Peptidase Inhibition and Analysis (7 papers). Chunlei Zhou is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Peptidase Inhibition and Analysis (7 papers). Chunlei Zhou collaborates with scholars based in China, United States and Canada. Chunlei Zhou's co-authors include Di Xu, Kejiang Cao, David Goltzman, Fengxiang Lu, Dengshun Miao, Jian-wei Ma, Cuiru Wang, Xinjian Liu, Jingfan Qiu and Delong Kong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Chunlei Zhou

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlei Zhou China 18 359 301 165 141 110 74 1.1k
Hua Yue China 23 738 2.1× 269 0.9× 80 0.5× 137 1.0× 263 2.4× 106 1.7k
Jun Huang China 22 649 1.8× 96 0.3× 84 0.5× 217 1.5× 69 0.6× 83 1.5k
Xinhua Yin China 22 590 1.6× 256 0.9× 129 0.8× 114 0.8× 86 0.8× 61 1.7k
Lixing Wang China 16 204 0.6× 240 0.8× 173 1.0× 46 0.3× 45 0.4× 41 1.1k
Hua Liang China 23 522 1.5× 125 0.4× 54 0.3× 211 1.5× 107 1.0× 87 1.5k
Qi Mao China 16 279 0.8× 59 0.2× 99 0.6× 86 0.6× 75 0.7× 65 1.1k
Daniela Farkas United States 20 773 2.2× 142 0.5× 163 1.0× 183 1.3× 88 0.8× 34 2.1k
Longkun Li China 27 635 1.8× 87 0.3× 121 0.7× 264 1.9× 120 1.1× 101 1.9k
Qiujun Yu China 18 436 1.2× 213 0.7× 31 0.2× 124 0.9× 51 0.5× 28 1.1k

Countries citing papers authored by Chunlei Zhou

Since Specialization
Citations

This map shows the geographic impact of Chunlei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlei Zhou more than expected).

Fields of papers citing papers by Chunlei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlei Zhou. The network helps show where Chunlei Zhou may publish in the future.

Co-authorship network of co-authors of Chunlei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlei Zhou. A scholar is included among the top collaborators of Chunlei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlei Zhou. Chunlei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiali, Bo Qian, Xiaowen Yu, et al.. (2025). T‐cell differentiation stage block bias confers hypermethylation and mediastinal preference in T‐cell lymphoblastic lymphoma. Clinical and Translational Medicine. 15(7). e70380–e70380.
2.
Zhang, Xinxin, Lei Lin, Lei Miao, et al.. (2025). Neuroblastoma risk decreased by NSUN3 rs7653521 C>T polymorphism in Chinese children. Chinese Medical Journal. 138(17). 2204–2206. 1 indexed citations
3.
Zhou, Chunlei, Wei Jia, Haixia Zhou, et al.. (2024). Polymorphisms in the NSUN1 gene and neuroblastoma risk in Chinese children from Jiangsu province. Journal of Cancer. 16(2). 622–628. 1 indexed citations
4.
Zhou, Chunlei, et al.. (2024). The impact of hypertension on clinical manifestations of Omicron variant BA.1 infection in adult patients. Microbiology Spectrum. 12(6). e0416823–e0416823.
5.
Li, Shuxuan, Chunlei Zhou, Wenjing Li, Lichun Kang, & Hong Mu. (2024). The effects of coagulation factors on the risk of autoimmune diseases: A Mendelian randomization study. Medicine. 103(52). e40893–e40893.
6.
Lin, Lei, Chunlei Zhou, Jinhong Zhu, et al.. (2023). miR‐100 rs1834306 a > G polymorphism decreases neuroblastoma risk in Chinese children. Cancer Reports. 6(10). e1875–e1875. 1 indexed citations
7.
Liu, Jiabin, Changmi Deng, Huiran Lin, et al.. (2023). Genetic variants of m7G modification genes influence neuroblastoma susceptibility. Heliyon. 10(1). e23658–e23658. 4 indexed citations
8.
Zhou, Chunlei, et al.. (2023). Clinical characteristics associated with recurrent viral RNA positivity in patients within two weeks after recovering from the first SARS-CoV-2 infection. SHILAP Revista de lepidopterología. 24(1). 196–204. 1 indexed citations
9.
Wang, Weijing, Chunlei Zhou, Xinxin Zhang, et al.. (2023). Association Between miR-492 rs2289030 G>C and Susceptibility to Neuroblastoma in Chinese Children from Jiangsu Province. 2(4). 199–203. 1 indexed citations
10.
Zhao, Jie, Jingyu Wang, Haixu Xu, et al.. (2023). Intervertebral Disk Degeneration and Bone Mineral Density: A Bidirectional Mendelian Randomization Study. Calcified Tissue International. 114(3). 228–236. 2 indexed citations
11.
Wu, Xiaohao, Minghao Qu, Weiyuan Gong, et al.. (2021). Kindlin-2 deletion in osteoprogenitors causes severe chondrodysplasia and low-turnover osteopenia in mice. Journal of Orthopaedic Translation. 32. 41–48. 20 indexed citations
12.
Zhou, Chunlei, Yizhen Wang, Lili He, et al.. (2020). Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population. Molecular Therapy — Oncolytics. 20. 3–11. 6 indexed citations
13.
Sun, Ping, et al.. (2017). [The study of serum complements and proinflammatory cytokines in sepsis rats].. PubMed. 29(4). 364–367. 1 indexed citations
14.
Zhou, Chunlei, Delong Kong, Jinfeng Liu, et al.. (2017). MHC II − , but not MHC II + , hepatic Stellate cells contribute to liver fibrosis of mice in infection with Schistosoma japonicum. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(7). 1848–1857. 5 indexed citations
15.
Zhou, Chunlei, Lan Zhao, Jian Zheng, et al.. (2017). MicroRNA-144 modulates oxidative stress tolerance in SH-SY5Y cells by regulating nuclear factor erythroid 2-related factor 2-glutathione axis. Neuroscience Letters. 655. 21–27. 44 indexed citations
16.
Chen, Dan, Wang Zh, Chunlei Zhou, et al.. (2014). Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. Journal of Molecular Neuroscience. 54(1). 1–9. 18 indexed citations
17.
Sun, Xi, Xi Sun, Ying Zhou, et al.. (2012). Unique roles of Schistosoma japonicum protein Sj16 to induce IFN‐γ and IL‐10 producing CD4+CD25+ regulatory T cells in vitro and in vivo. Parasite Immunology. 34(8-9). 430–439. 23 indexed citations
18.
Lv, Junqiang, Wen Zhang, Song Wang, et al.. (2010). The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage. Inflammation Research. 59(12). 1081–1089. 2 indexed citations
19.
Hu, Wang, et al.. (2008). Kaempferol: A new immunosuppressant of calcineurin. IUBMB Life. 60(8). 549–554. 25 indexed citations
20.
Zheng, Minna, Rong Lu, Jinping Li, et al.. (2006). Tyroservatide Therapy for Tumor Growth, Invasion and Metastasis of Lewis Lung Carcinoma and Human Lung Carcinoma A549. Oncology. 70(6). 418–426. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Yue Breakdown of academic impact, for papers by Jun Huang Breakdown of academic impact, for papers by Xinhua Yin Breakdown of academic impact, for papers by Lixing Wang Breakdown of academic impact, for papers by Hua Liang Breakdown of academic impact, for papers by Qi Mao Breakdown of academic impact, for papers by Daniela Farkas Breakdown of academic impact, for papers by Longkun Li Breakdown of academic impact, for papers by Qiujun Yu
Rankless by CCL
2026